Stock Trading Canary

United States · SEC Form 4 · Snapshot date: 2026-10-18 · Built: 2026-10-18 · 中文

← United States · Coverage record

US · SEC FORM 4

Indivior Pharmaceuticals, Inc.

INDV · Nasdaq · CIK 0001625297 · Healthcare · Drug Manufacturers—Specialty & Generic

INSIDER SIGNAL

No active buy signal

2 qualifying P purchase groups
in the current 180-day scoring window

15 Form 4 transaction lines observed in the same window
3 sales · 10 option, withholding, award, gift or other lines

Last qualifying purchase2026-08-27 · Anderson Woodrow D · $53.5K

WHY NO ACTIVE SIGNAL?

Purchase activityPresent
Recent buying2 qualifying line group(s)
Recent salesLow
Buy signal statusInactive
Score anatomy

No score is calculated because there is no qualifying purchase in the active window. Unavailable inputs are not treated as zero or as a bearish signal.

ClusterNot calculated
Purchase sizeNot calculated
RoleNot calculated
RecencyNot calculated
ConvictionNot calculated

Why is there no score?

  • No qualifying open-market purchase supplies cluster, size, role, recency or conviction inputs.
  • Sales and other Form 4 activity remain visible as context and do not create a negative score.

Sales and other Form 4 activity are shown separately and do not create a negative buy signal. Absence of buying is not scored as bearish.

Insider activity timeline

Owner lanes show the latest 180 days. Symbol shape identifies the transaction type; sales remain context only.

AprMayJunJulAugSepOct
Ciaffoni JosephChief Executive Officer
○○
Heidbreder ChristianChief Scientific Officer
▼▼
Thompson JulietDirector
○○
Anderson Woodrow DChief Accounting Officer
●●
Preblick RyanChief Financial Officer
▼
Humphreys KeithDirector
○
● Purchase▼ Sale○ Other

Showing the six most active owners; 5 additional owner(s) remain in Form 4 evidence.

Purchase breadth & concentration

QUALIFYING BUYERS1
PURCHASE CONCENTRATION100%Largest buyer: Anderson Woodrow D · $108.0K
CLUSTER BUYING · 15D1 insiderPeak activity: 2026-08-05–2026-08-05

Roles in the peak window: Chief Accounting Officer. Concentration uses priced qualifying P lines only and does not change the saved score.

SIGNAL HISTORY

No recorded active-signal snapshot

Scores are archived only when the company qualifies for a published US buy-signal snapshot. Last qualifying purchase: 2026-08-27 · Anderson Woodrow D.

Recent Form 4 activity

10Purchases
3Sales
35Other Form 4 lines
39SEC filings · 365 days
BUYING2 qualifying P line(s) · 180 days
SELLING3 sale line(s) · context only
OTHER10 exercise / withholding / award / gift / other lines
10b5-1 / PLANNEDNot assessed

P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.

Market context

Market context has not been captured for this ticker yet. The daily market-context job processes the US universe in rotating batches.

Short interest

Short interest is external context reported to FINRA by broker-dealers. It does not affect the Insider Signal.

Shares short
10,413,493
Previous report
11,172,005
Avg daily volume
1,980,311
Days to cover
5.3

FINRA settlement date: 2026-09-30 · Captured 2026-10-12 · FINRA equity short interest ↗. A share count, published about a week after each of two settlement dates a month; not a percentage of shares outstanding.

Historical equity purchases

Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.

Transaction dateReporting ownerTypeSecuritySharesAvg. priceApprox. valueSource
2026-08-27Anderson Woodrow DPurchase (P)Common Stock1,500USD 35.69USD 53,535SEC filing ↗
2026-08-05Anderson Woodrow DPurchase (P)Common Stock1,500USD 36.28USD 54,420SEC filing ↗
2026-03-13Ryan BarbaraPurchase (P)Common Stock8USD 31.09USD 249SEC filing ↗
2026-03-09Ryan BarbaraPurchase (P)Common Stock31USD 32.56USD 1,009SEC filing ↗
2026-03-06Kingsley Stuart APurchase (P)Common Stock940USD 31.87USD 29,958SEC filing ↗
2026-01-05Wheadon David E.Purchase (P)Ordinary Shares1,771USD 35.39USD 62,676SEC filing ↗
2026-01-05Stejbach MarkPurchase (P)Ordinary Shares775USD 35.39USD 27,427SEC filing ↗
2026-01-05Ryan BarbaraPurchase (P)Ordinary Shares775USD 35.39USD 27,427SEC filing ↗
2026-01-05NINIVAGGI DANIEL APurchase (P)Ordinary Shares775USD 35.39USD 27,427SEC filing ↗
2026-01-05Humphreys KeithPurchase (P)Ordinary Shares775USD 35.39USD 27,427SEC filing ↗

Form 4 evidence

48 transaction lines in the latest 365-day window; 48 in local history.

DateOwnerTypeSecuritySharesAvg. priceApprox. valueSource
2026-08-27Anderson Woodrow DPurchase (P)Common Stock1,500USD 35.69USD 53,535SEC filing ↗
2026-08-05Anderson Woodrow DPurchase (P)Common Stock1,500USD 36.28USD 54,420SEC filing ↗
2026-07-10Heidbreder ChristianSale (S)Common Stock18,586USD 41.14USD 764,628SEC filing ↗
Show recent Form 4 evidence (30 grouped rows)
DateOwnerTypeSecuritySharesAvg. priceApprox. valueSource
2026-08-27Anderson Woodrow DPurchase (P)Common Stock1,500USD 35.69USD 53,535SEC filing ↗
2026-08-05Anderson Woodrow DPurchase (P)Common Stock1,500USD 36.28USD 54,420SEC filing ↗
2026-07-10Heidbreder ChristianSale (S)Common Stock18,586USD 41.14USD 764,628SEC filing ↗
2026-06-22Ciaffoni JosephOption exercise / conversion (M)Common Stock1,266,903USD —USD —SEC filing ↗
2026-06-22Ciaffoni JosephTax withholding (F)Common Stock612,549USD 38.32USD 23,472,878SEC filing ↗
2026-06-11Heidbreder ChristianSale (S)Common Stock18,586USD 38.06USD 707,383SEC filing ↗
2026-06-08Preblick RyanSale (S)Common Stock36,000USD 37.70USD 1,357,200SEC filing ↗
2026-05-13Wheadon David E.Award / grant (A)Common Stock10,430USD 0.00USD 0SEC filing ↗
2026-05-13Thompson JulietAward / grant (A)Common Stock6,518USD 0.00USD 0SEC filing ↗
2026-05-13Stejbach MarkAward / grant (A)Common Stock6,518USD 0.00USD 0SEC filing ↗
2026-05-13Ryan BarbaraAward / grant (A)Common Stock6,518USD 0.00USD 0SEC filing ↗
2026-05-13NINIVAGGI DANIEL AAward / grant (A)Common Stock6,518USD 0.00USD 0SEC filing ↗
2026-05-13Kingsley Stuart AAward / grant (A)Common Stock6,518USD 0.00USD 0SEC filing ↗
2026-05-13Humphreys KeithAward / grant (A)Common Stock6,518USD 0.00USD 0SEC filing ↗
2026-05-12Thompson JulietTax withholding (F)Common Stock1,117USD 38.28USD 42,759SEC filing ↗
2026-03-14Preblick RyanOption exercise / conversion (M)Common Stock6,302USD —USD —SEC filing ↗
2026-03-14Preblick RyanTax withholding (F)Common Stock2,843USD 31.11USD 88,446SEC filing ↗
2026-03-13Ryan BarbaraPurchase (P)Common Stock8USD 31.09USD 249SEC filing ↗
2026-03-09Ryan BarbaraPurchase (P)Common Stock31USD 32.56USD 1,009SEC filing ↗
2026-03-06Kingsley Stuart APurchase (P)Common Stock940USD 31.87USD 29,958SEC filing ↗
2026-03-03Preblick RyanOption exercise / conversion (M)Common Stock86,949USD —USD —SEC filing ↗
2026-03-03Preblick RyanTax withholding (F)Common Stock87,597USD 31.98USD 2,801,352SEC filing ↗
2026-03-03Heidbreder ChristianOption exercise / conversion (M)Common Stock101,544USD —USD —SEC filing ↗
2026-03-03Heidbreder ChristianTax withholding (F)Common Stock45,797USD 31.98USD 1,464,588SEC filing ↗
2026-03-03Burris Jeffrey WOption exercise / conversion (M)Common Stock79,893USD —USD —SEC filing ↗
2026-03-03Burris Jeffrey WTax withholding (F)Common Stock36,032USD 31.98USD 1,152,303SEC filing ↗
2026-03-03Anderson Woodrow DOption exercise / conversion (M)Common Stock24,310USD —USD —SEC filing ↗
2026-03-03Anderson Woodrow DTax withholding (F)Common Stock10,965USD 31.98USD 350,661SEC filing ↗
2026-02-10Preblick RyanAward / grant (A)Common Stock37,358USD 0.00USD 0SEC filing ↗
2026-02-10Heidbreder ChristianAward / grant (A)Common Stock33,622USD 0.00USD 0SEC filing ↗

Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.

Snapshot & identity

Snapshot date2026-10-18
Ranking versionUS-v1.2
Data qualityPASS ELIGIBLE · —
TickerINDV
CIK0001625297
SectorHealthcare
IndustryDrug Manufacturers—Specialty & Generic Yahoo Finance
SEC SIC2834 Pharmaceutical Preparations
ExchangeNasdaq

Data coverage

Local Form 4 history48 transaction lines from 2026-01-05 to 2026-08-27
10 P purchase lines · 3 S sale lines · 35 other lines
SEC company submissionsOpen SEC filings ↗

Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.